Inovio Pharmaceuticals Inc. (NASDAQ: INO)
$1.8300
-0.0300 ( -1.61% ) 225.8K
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Market Data
Open
$1.8300
Previous close
$1.8600
Volume
225.8K
Market cap
$67.15M
Day range
$1.8210 - $1.9530
52 week range
$1.7400 - $14.7480
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Dec 18, 2024 |
| 8-k | 8K-related | 19 | Dec 16, 2024 |
| 8-k | 8K-related | 15 | Nov 14, 2024 |
| 10-q | Quarterly Reports | 70 | Nov 14, 2024 |
| 8-k | 8K-related | 16 | Aug 13, 2024 |
| 8-k | 8K-related | 15 | Aug 08, 2024 |
| 10-q | Quarterly Reports | 68 | Aug 08, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |
| 8-k | 8K-related | 13 | May 28, 2024 |
| 4 | Insider transactions | 1 | May 22, 2024 |